Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00564109
Recruitment Status : Unknown
Verified November 2007 by University of Zurich.
Recruitment status was:  Recruiting
First Posted : November 27, 2007
Last Update Posted : March 18, 2008
Information provided by:
University of Zurich

Brief Summary:
Retrospective analysis of PSP- and PAP-serum levels in trauma patients with soft tissue defects and possible correlation with the incidence and onset of infection and sepsis.

Condition or disease Intervention/treatment
Trauma Patients With Soft Tissue Defects Procedure: retrospective Observation

Study Type : Observational
Estimated Enrollment : 15 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : August 2005
Study Completion Date : January 2008

Resource links provided by the National Library of Medicine

Intervention Details:
  • Procedure: retrospective Observation
    retrospective Observation

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Trauma patients

Inclusion criteria:

  • Trauma patients submitted to the university hospital Zurich, aged 18-65 with soft tissue defects

Exclusion criteria:

  • Patients with known immunocompromising illnesses, drug abuse or infectious diseases.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00564109

Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich

Responsible Party: Marius Keel, University Hospital Zurich Identifier: NCT00564109     History of Changes
Other Study ID Numbers: StV 10-2003
First Posted: November 27, 2007    Key Record Dates
Last Update Posted: March 18, 2008
Last Verified: November 2007